Gallardo, Baby Boy .

HRN: 27-66-93  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2026
AMPICILLIN 1GM (VIAL)
04/09/2026
04/16/2026
IV
400mg
Q6h
Pcap C
Checking Initial Appropriateness 
04/10/2026
CEFUROXIME 750MG (VIAL)
04/10/2026
04/16/2026
IV
300mg
Q8
PCAP C
Checking Initial Appropriateness 
04/11/2026
CEFTRIAXONE 1G (VIAL)
04/11/2026
04/18/2026
IV DRIP
800mg
Q24hours
PCAP-C
Checking Initial Appropriateness 
04/12/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/12/2026
04/18/2026
IV
120mg
Q24hours
PCAP-D
Checking Initial Appropriateness 
04/13/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/13/2026
04/20/2026
IVT
400mg
Q6
PCAP-D
Checking Initial Appropriateness 
04/19/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/19/2026
04/26/2026
IV
120mg
Q24
PCAP-C
Checking Initial Appropriateness 
05/03/2026
CEFTAZIDIME 1GM (VIAL)
05/03/2026
05/10/2026
IV
400mg
Q8
Pcap
Checking Initial Appropriateness 
05/12/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
05/12/2026
05/19/2026
TIV
10.5mg
LD
CRBSI
Checking Initial Appropriateness 
05/12/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
05/12/2026
05/19/2026
TIV
9mg
Q8H
CRBSI
Checking Initial Appropriateness 
05/12/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/12/2026
05/19/2026
TIV
50mg
Q12H
CRBSI
Checking Initial Appropriateness 
05/12/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
05/12/2026
05/19/2026
TIV
60mg
Q24H
CRBSI
Checking Initial Appropriateness 
05/18/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/18/2026
05/25/2026
IV
50mg
Q12h
CRBSI
Checking Initial Appropriateness 
05/19/2026
MUPIROCIN 2%, 15G (TUBE)
05/19/2026
05/26/2026
TOPICAL
As Needed
BID
Skin Infection
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: